CA2930393C — Carbohydrate conjugates as delivery agents for oligonucleotides
Assigned to Alnylam Pharmaceuticals Inc · Expires 2022-11-29 · 3y expired
What this patent protects
In a preferred embodiment, there is provided a double stranded oligonucleotide comprising at least one conjugate structure at each strand, wherein the conjugate structure is , wherein n' is 3-6. The oligonucleotide is preferably for modulating the expression of a target gene in…
USPTO Abstract
In a preferred embodiment, there is provided a double stranded oligonucleotide comprising at least one conjugate structure at each strand, wherein the conjugate structure is , wherein n' is 3-6. The oligonucleotide is preferably for modulating the expression of a target gene in a cell.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.